AquaBounty Technologies (NASDAQ:AQB) Announces Quarterly Earnings Results

AquaBounty Technologies (NASDAQ:AQB) announced its quarterly earnings data on Tuesday. The company reported ($0.88) earnings per share for the quarter, meeting the consensus estimate of ($0.88), RTT News reports. AquaBounty Technologies had a negative return on equity of 17.81% and a negative net margin of 3,923.57%. The firm had revenue of $0.05 million during the quarter, compared to the consensus estimate of $0.10 million. During the same quarter in the previous year, the company posted ($1.60) earnings per share.

AquaBounty Technologies Trading Down 2.6 %

AQB traded down $0.03 during trading on Wednesday, hitting $1.12. 12,348 shares of the stock traded hands, compared to its average volume of 24,268. The firm has a 50-day moving average of $1.13 and a 200 day moving average of $1.47. AquaBounty Technologies has a 12-month low of $0.81 and a 12-month high of $4.03. The firm has a market capitalization of $4.33 million, a P/E ratio of -0.06 and a beta of 1.15. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.96 and a quick ratio of 1.96.

About AquaBounty Technologies

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.